
|Articles|February 1, 1997
Supplements and Featured Publications
- Looking Beyond the Formulary Budget: Cost Analysis and a Psychiatric Perspective
- Volume 3
- Issue 2 Suppl
Evaluating the Cost Effectiveness of Newer Psychotropic Medications
Author(s)Gary L. Viale, PharmD
Advertisement
Articles in this issue
almost 29 years ago
Introduction: Looking Beyond the Formulary Budgetalmost 29 years ago
Looking Beyond the Formulary Budget in Cost-Benefit Analysisalmost 29 years ago
Retrospective Analysis of the Effect of Risperidone on Clinical Outcomealmost 29 years ago
Newer Antipsychotic Medications: Discussionsalmost 29 years ago
Bibliographyalmost 29 years ago
ParticipantsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Detailed Liver Atlas Links Macrophage Activity to MASH Progression
3
Long-term CR Seen With Allo-CAR-NK Cell Therapy Plus Rituximab in Waldenstrom NHL
4
CheckMate 9LA at 6 Years Shows Enduring Benefits From Dual Immunotherapy Plus Chemotherapy in Metastatic NSCLC
5




























































